Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

HEXO Corp

Tilray Acquires HEXO On The Cheap In Surprise Move

So, it's settled: Canadian cannabis producer Tilray (NASDAQ: TLRY ) plans to acquire rival Hexo (NASDAQ: HEXO ). It's debatable, however, whether this is actually a good idea.

Is Tilray Stock a Buy or Sell? Here's My Call.

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have lowered their price target for Tilray Brands after the company announced it is acquiring its strategic partner HEXO for US$56 million in tandem with the release of its fiscal 3Q 2023 results earlier this week. In a note to clients, the analysts wrote that their updated price target was US$4.25, down from US$5, with a ‘Buy' rating.

Tilray Brands price target lowered after 3Q earnings and HEXO acquisition announcement

Tilray Brands (NASDAQ: TLRY) reported a mixed quarter and a deal to acquire HEXO that sent the market moving lower. While the news is less than spectacular, there are some takeaways for investors to be aware of.

Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher

Tilray disappointed investors with its fiscal third-quarter 2023 results. The Hexo acquisition will boost its market share and revenue.

Why Tilray Stock Sank and Moved the Canadian Cannabis Market Today

HEXO Corp shares fell more than 25% on Tuesday after the company revealed it will be acquired by Canadian cannabis market leader Tilray Brands for $56 million in an all-stock deal. After initially spiking on Monday to US$1.64 on rumors of the acquisition, HEXO's share price reversed sharply on confirmation of the deal.

HEXO shares reverse sharply on Tilray acquisition

Tilray Brands (NASDAQ: TLRY ) announced it is acquiring rival cannabis company Hexo (NASDAQ: HEXO ) as the industry continues to consolidate. The announcement was made in Tilray's earnings release.

HEXO Stock Alert: Tilray to Acquire Hexo in $56 Million Deal

Tilray Brands Inc. TLRY, +5.38% TLRY, +6.27% stock is down 8% in premarket trades Tuesday after the cannabis company posted a wider-than-expected loss, missed its revenue estimate and said it would buy fellow Canadian cannabis company Hexo Corp. HEXO, +30.16% for $56 million in an all-stock deal. Hexo stock is down 23%.

Tilray, Hexo stocks fall sharply after M&A deal

Tilray plans to acquire Hexo for $56 million. The two companies entered into a strategic alliance last year.

Is Tilray Stock a Buy With Its Acquisition of Hexo?

While the top- and bottom-line numbers for Tilray Brands, Inc. (TLRY) give a sense of how the business performed in the quarter ended February 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About Tilray Brands, Inc. (TLRY) Q3 Earnings

Tilray Brands, Inc. (NASDAQ:TLRY ) Q3 2023 Earnings Conference Call April 10, 2023 5:00 PM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - Chairman and Chief Executive Officer Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer and Head, International Blair MacNeil - President, Tilray Canada Ty Gilmore - President, U.S. Beer Business Conference Call Participants Vivien Azer - TD Cowen Andrew Carter - Stifel Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets Frederico Gomes - ATB Capital Markets John Zamparo - CIBC Michael Lavery - Piper Sandler Operator Good afternoon, everyone. Thank you for joining us to discuss Tilray Brands, Inc.'s Financial Results for the Full Year 2023 Third Quarter Ended February 28, 2023.

Tilray Brands, Inc. (TLRY) Q3 2023 Earnings Call Transcript

Shares of Tilray Inc (NASDAQ: TLRY) is trading down in extended hours after the cannabis company said it swung to a loss in its third financial quarter. Tilray Q3 financial highlights Tilray continues to expect its operating segments to deliver positive free cash flow in FY23.

Tilray is buying HEXO Corp despite Q3 loss

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.04 per share a year ago.

Tilray Brands, Inc. (TLRY) Reports Q3 Loss, Lags Revenue Estimates

Delivered $145.6 Million in Net Revenue and 16 th Consecutive Quarter of Positive Adjusted EBITDA

CORRECTION--Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp.

Canadian pot producer Tilray Brands Inc. on Monday said it would buy rival Hexo Corp. for $56 million, after years of losses, steep competition and stalled federal reform in the U.S. have weighed on the industry's growth prospects.

Tilray wants to buy Hexo, marking further Canadian cannabis consolidation

Tilray Brands will acquire its rival HEXO Corp for US$56 million through the issuance of 0.4352 Tilray shares for each outstanding HEXO share, the company announced along with the release of its fiscal third quarter 2023 results.  The acquisition will strengthen Tilray's leading position in the Canadian cannabis market to a 12.9% pro-forma market share, the company said.

Tilray Brands to acquire rival cannabis company HEXO for US$56M

Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp.

I have been following Tilray closely since it went public, and I closely followed Aphria, which it acquired, even earlier. The stock is way down from its IPO price and its peak price, but it's not attractive in my view.

You Should Stay Away From Tilray

American Well Corporation

B2Gold

Ammo

Super Group SGHC Ltd

Solid Power

Uranium Energy

Before entertaining the discussion of the top penny stocks to watch, it is imperative to emphasize that this market arena requires caution before investing. It looks as if 2023 could be a prosperous year for stocks.

7 Penny Stocks to Keep an Eye on for the Rest of the Year

SNDL Inc.

2 Marijuana Stocks To Buy This Week For Better Momentum? The post Top Marijuana Stocks To Watch 2nd Week Of April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch 2nd Week Of April

Bitfarms Ltd

Curaleaf Holdings, Inc.

Harmony Gold Mining Co Ltd

Polestar Automotive Holding UK PLC

Waterdrop

While some of the top penny stocks to buy carry risk, there are still plenty of opportunities to be found. In fact, today, my focus is on some thrilling penny stocks that investors may want to consider at current levels.

7 Thrilling Penny Stocks for Aggressive Investors to Buy

OrganiGram Holdings Inc.

After a tough 2022 for cannabis stocks, investors will be looking to companies such as Tilray Brands and Organigram Holdings as they report their latest quarterly results to see how the industry is faring in the first three months of 2023. New York-based Tilray is set to report its 3Q fiscal 2023 results after the market close on April 10, but analysts aren't too optimistic about the company's recent performance.

Tilray and Organigram to report earnings: can either cannabis company deliver an upside surprise?

Albertsons Companies

CarMax

Shortly after Thursday's opening bell, the Dow was trading down 0.13%, the S&P 500 down 0.37% and the Nasdaq Composite 0.74% lower.

Earnings Previews: Albertsons, CarMax, Tilray

COLOGNE, Germany, April 06, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has expanded its European footprint across the Czech Republic through a new export and distribution partnership with Cansativa Group. The new strategic partnership broadens Tilray Medical's distribution of EU-GMP certified medical cannabis products across pharmacies and hospitals to support medical cannabis patient care.

Tilray Medical Expands Commercial Footprint in Europe and Broadens Distribution Across the Czech Republic

SweetWater, Green Flash, and Alpine Beer's Iconic Craft Beers Now Available Across 44 States in the U.S. SweetWater, Green Flash, and Alpine Beer's Iconic Craft Beers Now Available Across 44 States in the U.S.

News for Tilray Brands Stock (TLRY)